Magda Bujar is an accomplished professional in the field of regulatory science, currently serving as Associate Director at the Centre for Innovation in Regulatory Science (CIRS) since January 2019. Prior roles at CIRS include Senior Manager of Regulatory Programme and Strategic Partnerships and Manager of Strategic Development. Magda's extensive experience also encompasses positions as Project Manager, Senior Research Analyst, and Research Analyst at the Centre for Innovation in Regulatory Science, Ltd from September 2013 to January 2019. Initial career steps included roles as Analytical Research Scientist and Research Assistant at the University of Bristol from April 2011 to April 2012. Educational qualifications include a Doctor of Philosophy (Ph.D.) in Pharmacy with a focus on Regulatory Affairs from the University of Hertfordshire, a Short Course in the Foundation of Decision Analysis from Stanford University, a Master of Science (MSc) in Biochemical Engineering from UCL, a Bachelor of Science (BSc) in Biochemistry from the University of Bristol, and a European Baccalaureate from the European School of Mol.
This person is not in any teams
CIRS - Centre for Innovation in Regulatory Science
The Centre for Innovation in Regulatory Science (CIRS) is a neutral, independently managed UK-based subsidiary of Clarivate plc. CIRS provides an international forum for industry, regulators, HTA and other healthcare stakeholders to meet, debate and develop regulatory and reimbursement policy through the innovative application of regulatory science and to facilitate access to pharmaceutical products. It is governed and operated by Clarivate for the sole support of its members’ activities. The organisation has its own dedicated management and advisory boards, and its funding is derived from membership dues, related activities, special projects and grants.